vs

Side-by-side financial comparison of ExlService Holdings, Inc. (EXLS) and Tempus AI, Inc. (TEM). Click either name above to swap in a different company.

ExlService Holdings, Inc. is the larger business by last-quarter revenue ($542.6M vs $367.2M, roughly 1.5× Tempus AI, Inc.). ExlService Holdings, Inc. runs the higher net margin — 11.1% vs -14.8%, a 25.9% gap on every dollar of revenue. On growth, Tempus AI, Inc. posted the faster year-over-year revenue change (83.0% vs 12.7%). ExlService Holdings, Inc. produced more free cash flow last quarter ($106.5M vs $-41.5M). Over the past eight quarters, Tempus AI, Inc.'s revenue compounded faster (58.7% CAGR vs 11.5%).

Exlservice Holdings, Inc. is a global analytics and digital solutions company serving industries including insurance, healthcare, banking and financial services, media, retail, and others. The company is headquartered in New York and has more than 54,000 professionals in locations throughout the United States, Europe, Asia, Latin America, Australia and South Africa.

Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."

EXLS vs TEM — Head-to-Head

Bigger by revenue
EXLS
EXLS
1.5× larger
EXLS
$542.6M
$367.2M
TEM
Growing faster (revenue YoY)
TEM
TEM
+70.3% gap
TEM
83.0%
12.7%
EXLS
Higher net margin
EXLS
EXLS
25.9% more per $
EXLS
11.1%
-14.8%
TEM
More free cash flow
EXLS
EXLS
$148.1M more FCF
EXLS
$106.5M
$-41.5M
TEM
Faster 2-yr revenue CAGR
TEM
TEM
Annualised
TEM
58.7%
11.5%
EXLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EXLS
EXLS
TEM
TEM
Revenue
$542.6M
$367.2M
Net Profit
$60.2M
$-54.2M
Gross Margin
38.6%
Operating Margin
14.4%
-16.7%
Net Margin
11.1%
-14.8%
Revenue YoY
12.7%
83.0%
Net Profit YoY
18.9%
-316.2%
EPS (diluted)
$0.38
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXLS
EXLS
TEM
TEM
Q4 25
$542.6M
$367.2M
Q3 25
$529.6M
$334.2M
Q2 25
$514.5M
$314.6M
Q1 25
$501.0M
$255.7M
Q4 24
$481.4M
$200.7M
Q3 24
$472.1M
$180.9M
Q2 24
$448.4M
$166.0M
Q1 24
$436.5M
$145.8M
Net Profit
EXLS
EXLS
TEM
TEM
Q4 25
$60.2M
$-54.2M
Q3 25
$58.2M
$-80.0M
Q2 25
$66.1M
$-42.8M
Q1 25
$66.6M
$-68.0M
Q4 24
$50.7M
$-13.0M
Q3 24
$53.0M
$-75.8M
Q2 24
$45.8M
$-552.2M
Q1 24
$48.8M
$-64.7M
Gross Margin
EXLS
EXLS
TEM
TEM
Q4 25
38.6%
Q3 25
38.5%
Q2 25
37.7%
Q1 25
38.6%
Q4 24
38.1%
Q3 24
37.8%
Q2 24
37.1%
Q1 24
37.4%
Operating Margin
EXLS
EXLS
TEM
TEM
Q4 25
14.4%
-16.7%
Q3 25
14.4%
-18.3%
Q2 25
15.8%
-19.6%
Q1 25
15.7%
-26.9%
Q4 24
14.8%
-25.3%
Q3 24
14.7%
-29.6%
Q2 24
13.7%
-321.4%
Q1 24
14.1%
-36.5%
Net Margin
EXLS
EXLS
TEM
TEM
Q4 25
11.1%
-14.8%
Q3 25
11.0%
-23.9%
Q2 25
12.8%
-13.6%
Q1 25
13.3%
-26.6%
Q4 24
10.5%
-6.5%
Q3 24
11.2%
-41.9%
Q2 24
10.2%
-332.7%
Q1 24
11.2%
-44.4%
EPS (diluted)
EXLS
EXLS
TEM
TEM
Q4 25
$0.38
$-0.30
Q3 25
$0.36
$-0.46
Q2 25
$0.40
$-0.25
Q1 25
$0.40
$-0.40
Q4 24
$0.31
$2.56
Q3 24
$0.33
$-0.46
Q2 24
$0.28
$-6.86
Q1 24
$0.29
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXLS
EXLS
TEM
TEM
Cash + ST InvestmentsLiquidity on hand
$328.4M
$604.8M
Total DebtLower is stronger
$298.6M
Stockholders' EquityBook value
$912.7M
$491.3M
Total Assets
$1.7B
$2.3B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXLS
EXLS
TEM
TEM
Q4 25
$328.4M
$604.8M
Q3 25
$390.1M
$655.9M
Q2 25
$353.3M
$186.3M
Q1 25
$331.4M
$151.6M
Q4 24
$340.6M
$341.0M
Q3 24
$325.8M
$388.0M
Q2 24
$276.1M
$478.8M
Q1 24
$246.2M
$79.9M
Total Debt
EXLS
EXLS
TEM
TEM
Q4 25
$298.6M
Q3 25
$354.8M
Q2 25
$260.0M
Q1 25
$307.3M
Q4 24
$288.5M
Q3 24
$344.7M
Q2 24
Q1 24
Stockholders' Equity
EXLS
EXLS
TEM
TEM
Q4 25
$912.7M
$491.3M
Q3 25
$952.4M
$507.8M
Q2 25
$1.1B
$309.6M
Q1 25
$1.0B
$326.2M
Q4 24
$929.9M
$56.3M
Q3 24
$907.6M
$53.7M
Q2 24
$852.6M
$98.3M
Q1 24
$803.3M
$-1.5B
Total Assets
EXLS
EXLS
TEM
TEM
Q4 25
$1.7B
$2.3B
Q3 25
$1.7B
$2.3B
Q2 25
$1.7B
$1.6B
Q1 25
$1.7B
$1.5B
Q4 24
$1.6B
$926.1M
Q3 24
$1.6B
$971.7M
Q2 24
$1.5B
$864.6M
Q1 24
$1.4B
Debt / Equity
EXLS
EXLS
TEM
TEM
Q4 25
0.33×
Q3 25
0.37×
Q2 25
0.25×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.38×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXLS
EXLS
TEM
TEM
Operating Cash FlowLast quarter
$117.4M
$-36.8M
Free Cash FlowOCF − Capex
$106.5M
$-41.5M
FCF MarginFCF / Revenue
19.6%
-11.3%
Capex IntensityCapex / Revenue
2.0%
1.3%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$298.1M
$-239.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXLS
EXLS
TEM
TEM
Q4 25
$117.4M
$-36.8M
Q3 25
$120.7M
$-119.8M
Q2 25
$109.4M
$44.2M
Q1 25
$3.2M
$-105.6M
Q4 24
$105.3M
Q3 24
$110.1M
$48.7M
Q2 24
$74.9M
$-97.1M
Q1 24
$-21.9M
$-101.4M
Free Cash Flow
EXLS
EXLS
TEM
TEM
Q4 25
$106.5M
$-41.5M
Q3 25
$106.4M
$-126.5M
Q2 25
$95.0M
$36.6M
Q1 25
$-9.7M
$-107.7M
Q4 24
$95.3M
Q3 24
$97.3M
$48.6M
Q2 24
$62.8M
$-105.1M
Q1 24
$-33.1M
$-107.5M
FCF Margin
EXLS
EXLS
TEM
TEM
Q4 25
19.6%
-11.3%
Q3 25
20.1%
-37.9%
Q2 25
18.5%
11.6%
Q1 25
-1.9%
-42.1%
Q4 24
19.8%
Q3 24
20.6%
26.9%
Q2 24
14.0%
-63.3%
Q1 24
-7.6%
-73.7%
Capex Intensity
EXLS
EXLS
TEM
TEM
Q4 25
2.0%
1.3%
Q3 25
2.7%
2.0%
Q2 25
2.8%
2.4%
Q1 25
2.6%
0.8%
Q4 24
2.1%
Q3 24
2.7%
0.0%
Q2 24
2.7%
4.8%
Q1 24
2.6%
4.2%
Cash Conversion
EXLS
EXLS
TEM
TEM
Q4 25
1.95×
Q3 25
2.08×
Q2 25
1.66×
Q1 25
0.05×
Q4 24
2.08×
Q3 24
2.08×
Q2 24
1.63×
Q1 24
-0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXLS
EXLS

Insurance$185.8M34%
Healthcare And Life Sciences$142.2M26%
Banking Capital Markets And Diversified Industries$122.6M23%
International Growth Markets$92.0M17%

TEM
TEM

Segment breakdown not available.

Related Comparisons